The Patient Equation

Precision Medicine Revolution in the Age of COVID-19 and Beyond

The Patient Equation
Jeremy Blachman, Glen de Vries
RRP:
NZ$ 56.99
Our Price:
NZ$ 48.44
Hardback
h231 x 157mm - 288pg
5 Aug 2020 US
International import eta 10-30 days
9781119622147
Out Of Stock
Currently no stock in-store, stock is sourced to your order
How the data revolution is transforming biotech and health care, especially in the wake of COVID-19-and why you can't afford to let it pass you byWe are living through a time when the digitization of health and medicine is becoming a reality, with new abilities to improve outcomes for patients as well as the efficiency and success of the organizations that serve them. In The Patient Equation, Glen de Vries presents the history and current state of life sciences and health care as well as crucial insights and strategies to help scientists, physicians, executives, and patients survive and thrive, with an eye toward how COVID-19 has accelerated the need for change. One of the biggest challenges facing biotech, pharma, and medical device companies today is how to integrate new knowledge, new data, and new technologies to get the right treatments to the right patients at precisely the right times-made even more profound in the midst of a pandemic and in the years to come.Drawing on the fascinating stories of businesses and individuals that are already making inroads-from a fertility-tracking bracelet changing the game for couples looking to get pregnant, to an entrepreneur reinventing the treatment of diabetes, to Medidata's own work bringing clinical trials into the 21st century-de Vries shares the breakthroughs, approaches, and practical business techniques that will allow companies to stay ahead of the curve and deliver solutions faster, cheaper, and more successfully-while still upholding the principles of traditional therapeutic medicine and reflecting the current environment.How new approaches to cancer and rare diseases are leading the way toward precision medicineWhat data and digital technologies enable in the building of robust, effective disease management platformsWhy value-based reimbursement is changing the business of life sciencesHow the right alignment of incentives will improve outcomes at every stage of the patient journeyWhether you're a scientist, physician, or executive, you can't afford to let the moment pass: understand the landscape with this must-read roadmap for success-and see how you can change health care for the better.
GLEN DE VRIES is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Systemes. Glen has been driving Medidata's mission since the company's inception in 1999, "powering smarter treatments and healthier people" by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen's work has appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He also serves as a trustee of Carnegie Mellon University.JEREMY BLACHMAN is a writer who works with leaders across industries on getting their ideas out to the world. He has published two novels and developed television pilots for NBC. His writing has appeared in The New York Times, The Wall Street Journal, and many other prominent publications.
Status: Active
ISBN-13: 9781119622147
Published: 5 Aug 2020
Published In: United States
Imprint: John Wiley & Sons
Publisher: John Wiley & Sons
Format: Hardback
Height: 231mm
Width: 157mm
Spine: 31mm
Weight: 453g
Pages: 288

In stock - for items in stock we aim to dispatch the next business day. For delivery in NZ allow 2-5 business days, with rural taking a wee bit longer.

Locally sourced in NZ - stock comes from a NZ supplier with an approximate delivery of 7-15 business days.

International Imports - stock is imported into NZ, depending on air or sea shipping option from the international supplier stock can take 10-30 working days to arrive into NZ. 

Pre-order Titles - delivery will vary depending on where the title is published, if local stock is available in NZ then 5-7 business days, for international imports it can be 10-30 business days. In all cases we will access the quickest supply option.

Delivery Packaging - we ship all items in cardboard sleeves or by box with either packing paper or corn starch chips. (We avoid using plastics bubble bags)

Tracking - Orders are delivered by track and trace courier and are fully insured, tracking information will be sent by email once dispatched.

View our full Order & Delivery information

Details of the product above will be automatically included with your enquiry.